Cipla has entered into definitive agreements on 15 May 2024 for further investment of upto Rs 26 crore in Achira Labs, an associate company.
The follow-on investment shall strengthen Cipla’s partnership with Achira, enabling penetration into business domain of designing, developing and
manufacturing microfluidics based PoC immunoassay and molecular assay technologies.
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: May 15 2024 | 6:32 PM IST
